
Currently weight loss is the most effective treatment for NAFLD (even in the minority of patients who do not have obesity) and is at recommended in all national and international guidelines. Accumulating evidence has shown that weight loss, whether achieved by diet and lifestyle interventions, bariatric surgery or pharmacotherapy can improve biomarkers of NAFLD, as well as prevent progression, and in some cases reverse, fibrosis. Pharmacotherapy with anti obesity medications alone, or in combination with intensive lifestyle interventions or other weight loss drugs is closing the efficacy gap between diet and exercise and weight loss surgery. Give the importance of providing effective weight loss treatment to patients with NAFLD, weight management services need to be made increasingly available and embedded within hepatology services.
Like
Save
Share